Global alignment of immunization safety assessment in pregnancy – The GAIA project

Vaccine

Volumn 34, Issue 49, 2016, Pages 5993-5997

  Bonhoeffer, Jan ^a,b   Kochhar, Sonali ^c   Hirschfeld, Steven ^d   Heath, Paul T ^e   Jones, Christine E ^e   Bauwens, Jorgen ^a   Honrado, Ángel ^f   Heininger, Ulrich ^b   Muñoz, Flor M ^g   Eckert, Linda ^h   Steinhoff, Mark ⁱ   Black, Steven ⁱ   Padula, Michael ^j   Sturkenboom, Miriam ^k   Buttery, Jim ^l   Pless, Robert ^m   Zuber, Patrick ⁿ  

^a Brighton Collaboration Foundation   (Switzerland)

^b UNIVERSITY CHILDREN S HOSPITAL   (Switzerland)

^c Healthcare Management Consultants   (India)

^d EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH AND HUMAN DEVELOPMENT   (United States)

^e UNIVERSITY OF LONDON   (United Kingdom)

^f Synapse Research Management Partners   (Spain)

^g BAYLOR COLLEGE OF MEDICINE   (United States)

^h UNIVERSITY OF WASHINGTON   (United States)

ⁱ CINCINNATI CHILDREN'S HOSPITAL MEDICAL CENTER   (United States)

^j CHILDREN S HOSPITAL OF PHILADELPHIA   (United States)

^k ERASMUS MEDICAL CENTER   (Netherlands)

^l MONASH UNIVERSITY   (Australia)

^m PUBLIC HEALTH AGENCY OF CANADA   (Canada)

ⁿ WORLD HEALTH ORGANIZATION   (Switzerland)

more..

Author keywords

[No Author keywords available]

Indexed keywords

VACCINE;

ARTICLE; CONSENSUS; FEMALE; HUMAN; IMMUNIZATION; MEDICAL DOCUMENTATION; MIDDLE INCOME COUNTRY; NEWBORN CARE; NOMENCLATURE; OUTCOME ASSESSMENT; PREGNANCY; PREGNANCY OUTCOME; PREGNANT WOMAN; PREVENTIVE HEALTH SERVICE; PRIORITY JOURNAL; RISK ASSESSMENT; CLINICAL TRIAL (TOPIC); GLOBAL HEALTH; WORLD HEALTH ORGANIZATION;

CLINICAL TRIALS AS TOPIC; FEMALE; GLOBAL HEALTH; HUMANS; IMMUNIZATION; PREGNANCY; VACCINES; WORLD HEALTH ORGANIZATION;

EID: 84991199818     PISSN: 0264410X     EISSN: 18732518     Source Type: Journal    
DOI: 10.1016/j.vaccine.2016.07.006     Document Type: Article

References (32)

1. [1] United Nations Health Sustainable Development Goals. Website available at < http://www. un. org/sustainabledevelopment/health/>, [last accessed 20 May 2016].
2. [2] World Health Organization. Maternal Immunization Project. Website available at < http://www. who. int/immunization/research/development/influenza_maternal_immunization/en/>, [last accessed 20 May 2016].
3. [3] World Health Organization Weekly Epidemiological Record. Vaccines against influenza WHO position paper – November 2012, WER No. 47, 2012, 87, 461–476 available at: < http://www. who. int/wer>.
4. [4] World Health Organization Weekly Epidemiological Record. Meeting of the Strategic Advisory Group of Experts on immunization, November 2013 – conclusions and recommendations. Vaccination of pregnant and lactating women. WER No. 1, 2014, 89, 1–20, available at: < http://www. who. int/wer>, [last accessed May 20 2016].
5. [5] World Health Organization. Weekly Epidemiologic Record. Revised guidance on the choice of pertussis vaccines: July 2014. 2014 Jul 25; 89(30): 337–40.
6. [6] Zaman, K., et al. Effectiveness of maternal influenza immunization in mothers and infants. N Engl J Med 359 (2008), 1155–1164.
7. [7] Madhi, S.A., Cutland, C.L., Kuwanda, L., Weingberg, A., Hugo, A., Jones, S., et al. Influenza vaccination of pregnant women and protection of their infants. N Engl J Med 371 (2014), 918–931.
8. [8] Bill &Melinda Gates Foundation. Website available at < http://www. gatesfoundation. org/What-We-Do/Global-Health/Pneumonia#AreasofFocus>, [last accessed May 20 2016].
9. [9] Bonhoeffer, J., Heininger, U., Adverse events following immunization: perception and evidence. Curr Opin Infect Dis 20:3 (2007 Jun), 237–246.
10. [10] Izurieta, H.S., Zuber, P., Bonhoeffer, J., et al. Roadmap for the international collaborative epidemiologic monitoring of safety and effectiveness of new high priority vaccines. Vaccine 31:35 (2013), 3623–3627.
11. [11] Amarasinghe, A., Black, S., Bonhoeffer, J., et al. Effective vaccine safety systems in all countries: a challenge for more equitable access to immunization. Vaccine, 31(Suppl 2), 2013 Apr 18.
12. [12] The Global Vaccine Safety Initiative. Website available at < http://www. who. int/vaccine_safety/initiative/en/>, [last accessed May 20, 2016].
13. [13] WHO and Brighton Collaboration Consultative Meeting Report, available at: < http://www. who. int/immunization/research/meetings_workshops/brighton_keyterms_safety_pregnancy. pdf?ua=1>.
14. [14] GAIA Project. Partners and Working Group Members. < http://gaia-consortium. net/>.
15. [15] Fulton, T.R., Narayanan, D., Bonhoeffer, J., Ortiz, J.R., Lambach, P., Omer, S.B., A systematic review of adverse events following immunization during pregnancy and the newborn period. Vaccine 33:47 (2015), 6453–6465.
16. [16] Brighton Collaboration. Website available at < http://brightoncollaboration. org/public/what-we-do/setting-standards/case-definitions/process. html>, [last accessed May 20, 2016].
17. [17] Munoz, F.M., Eckert, L.O., Katz, M.A., Lambach, P., Ortiz, J.R., Bauwens, J., et al. Key terms for the assessment of the safety of vaccines in pregnancy: results of a global consultative process to initiate harmonization of adverse event definitions. Vaccine 33:47 (2015), 6441–6452.
18. [18] DeSilva, M., Munoz, F.M., Mcmillan, M., Tse Kawai, A., Marshall, H., Macartney, K.K., et al. Congenital anomalies: case definition & guidelines for collection, analysis, and presentation of immunisation safety data. Vaccine, 2016 [this issue].
19. [19] Pathirana, J., Muñoz, F.M., Abbing-Karahagopian, V., Bhat, N., Harris, T., Kapoor, A., et al. Neonatal death: case definition & guidelines for collection, analysis, and presentation of immunization safety data. Vaccine, 2016 [this issue].
20. [20] Vergnano, S., Buttery, J., Cailes, B., Chandrasekaran, R., Chiappini, E., Clark, E., et al. Neonatal infections: case definition & guidelines for collection, analysis, and presentation of immunization safety data. Vaccine, 2016 [this issue].
21. [21] Quinn, J., Munoz, F.M., Gonik, B., Frau, L., Cutland, C., Mallett-Moore, T., et al. Preterm birth: case definition; guidelines for collection, analysis, and presentation of immunisation safety data. Vaccine, 2016 [this issue].
22. [22] Tavares Da Silva, F., Gonik, B., McMillan, M., Keech, C., Dellicour, S., Bhange, S., et al. Stillbirth: case definition & guidelines for collection, analysis, and presentation of immunization safety data. Vaccine, 2016 [this issue].
23. [23] Rouse, C.E., Eckert, L.O., Wylie, B.J., Lyell, D.J., Jeyabalan, A., et al. Hypertensive disorders of pregnancy: case definitions & guidelines for collection, analysis and presentation of immunisation safety data. Vaccine, 2016 [this issue].
24. [24] Patwardhan, M., Eckert, L.O., Spiegel, H.M.L., Pourmalek, F., Cutland, C., Kochhar, S., et al. Maternal death: case definition; guidelines for collection, analysis, and presentation of immunisation safety data. Vaccine, 2016 [this issue].
25. [25] Gravett, C., Eckert, L.O., Gravett, M.G., Dudley, D.J., Stringer, E.M., Bodjick Muena Mujobu, T., et al. Non-reassuring fetal status: case definition & guidelines for collection, analysis, and presentation of immunisation safety data. Vaccine, 2016 [this issue].
26. [26] Kerr, R., Eckert, L.O., Winikoff, W., Durocher, J., Meher, S., Fawcus, S., et al. Postpartum haemorrhage: case definition & guidelines for collection, analysis, and presentation of immunization safety data. Vaccine, 2016 [this issue].
27. [27] Harrison, M.S., Eckert, L.O., Cutland, C., Gravett, M., Harper, D.M., McClure, E.M., et al. Pathways to preterm birth: case definition & guidelines for collection, analysis, and presentation of immunisation safety data. Vaccine, 2016 [this issue].
28. [28] Jones, C.E., Munoz, F.M., Spiegel, H.M.L., Heininger, U., Zuber, P.L.F., Edwards, K.M., et al. Guideline for collection, analysis and presentation of safety data in clinical trials of vaccines in pregnant women. Vaccine, 2016 [this issue].
29. [29] Jones, C.E., Munoz, F.M., Kochhar, S., Vergnano, S., Cutland, C., Steinhoff, M., et al. Guidance for the collection of case report form variables to assess safety in clinical trials of vaccines in pregnancy. Vaccine, 2016 [this issue].
30. [30] BC https://brightoncollaboration. org/public/what-we-do/capacity-buidling/abc. html.
31. [31] GAIA Consortium website, available at: < http://gaia-consortium. net>, [accessed May 30, 2015].
32. [32] Brighton Collaboration resources, website available at: < http://brightoncollaboration. org/public/resources/standards/case-definitions/pregnancy. html>, [accessed April 25, 2015].